Steve Schonfeld’s Arcturus Therapeutics ARCT Stock Holding History

Steve Schonfeld’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-230,500	Closed	-$3.63M	–	2931
2022 Q2	$3.63M	Buy	+230,500	New	+$4.52M	0.04%	557
2022 Q1	–	Sell	-275,000	Closed	-$10.2M	–	2572
2021 Q4	$10.2M	Buy	275,000 +225,000	+450%	+$9.17M	0.09%	282
2021 Q3	$2.39M	Buy	+50,000	New	+$2.24M	0.02%	654
2020 Q4	–	Sell	-50,000	Closed	-$2.15M	–	1556
2020 Q3	$2.15M	Buy	+50,000	New	+$2.48M	0.04%	494

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Steve Schonfeld's ARCT Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 26,315 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #2217 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ARCT as recently as Q4 2025.

Steve Schonfeld first reported a position in ARCT in Q2 2020 and has held it in 21 quarters since. The position peaked at $14.4M in Q4 2024. 134 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

Steve Schonfeld held 26,315 shares of Arcturus Therapeutics worth $177K as of Q2 2026.
Arcturus Therapeutics was a new Steve Schonfeld position in Q2 2026.
Arcturus Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2217 holding.
Steve Schonfeld first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 21 quarters since.
Steve Schonfeld's Arcturus Therapeutics position peaked at $14.4M in Q4 2024.
134 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.